Induction of tolerance in humans: Effectiveness of oral and nasal immunization routes

Annals of the New York Academy of Sciences

Volumn 778, Issue , 1996, Pages 194-201

  Mestecky, Jiri ^a   Hussy, Steffen ^a,b   Moldoveanu, Zina ^a   Waldo, F Bryson ^c   Van Den Wall Bake, A W L ^a,d   Elson, Charles O ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UAB   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; NEUTRALIZING ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTACT ALLERGY; DESENSITIZATION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INTRANASAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; ORAL DRUG ADMINISTRATION; SKIN TEST; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0029976178     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb21128.x     Document Type: Article

References (25)

1. MOWAT, A. MCL. 1994. Oral tolerance and regulation of immunity to dietary-antigens. In Handbook of Mucosal Immunology. P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee & J. Bienenstock, Eds.: 185-201. Academic Press. San Diego, CA.
2. KAGNOFF, M. F. 1982. Oral tolerance. Ann. N. Y. Acad. Sci. 392: 248-265.
3. WEINER, H. L., G. A. MACKIN, M. MATSUI, E. M. ORAV, S. J. KHOURY, D. M. DAWSON & D. A. HAFLER. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321-1324.
4. TRENTHAM, D. E., R. A. DYNESIUS-TRENTHAM, E. J. ORAV, D. COMBITCHI, C. LORENZO, K. L. SEWELL, D. A. HAFLER & H. L. WEINER. 1993. Effects of oral administration of Type II collagen or rheumatoid arthritis. Science 261: 1727-1730.
5. TAUDORF, E., L. C. LAURSEN, A. LANNER, B. BJÖRKSTEN, S. DREBORG, M. SOBORG & B. WEEKE. 1987. Oral immunotherapy in birch pollen hay fever. J. Allergy Clin. Immunol. 80: 153-156.
6. MESTECKY, J., M. W. RUSSELL & M. KILIAN. 1995. The potential role of IgA-mediated mucosal immunity in the prevention of hypersensitivity reactions in the respiratory tract. In Progress in Allergy and Clinical Immunology. S. G. O. Johansson, Ed.: 3:45-49. Hogrefe & Huber Publisher. Seattle.
7. MCGHEE, J. R. & J. MESTECKY. 1990. In defense of mucosal surfaces. Development of novel vaccines for IgA response protective at the portals of entry of microbial pathogens. Infect. Dis. Clin. North Am. 4(2): 315-341.
8. MESTECKY, J. & J. R. MCGHEE, EDS. 1989. New strategies for oral immunization. Curr. Top. Microbiol. Immunol. 146: 3-237.
9. CHALLACOMBE, S. J. & T. B. TOMASI, JR. 1980. Systemic tolerance and secretory immunity after oral immunization. J. Exp. Med. 153: 1459-1472.
10. MESTECKY, J., M. W. RUSSELL, S. JACKSON & T. A. BROWN. 1986. The human IgA system: A reassessment. Clin. Immunol. Immunopathol. 40: 105-114.
11. CONLEY, M. E. & D. L. DELACROIX. 1987. Intravascular and mucosal immunoglobulin A: Two separate but related systems of immune defense? Ann. Intern. Med. 106: 892-899.
12. HOLT, P. G., J. E. BATTY & K. J. TURNER. 1981. Inhibition of specific IgE response in mice by pre-exposure to inhaled antigen. Immunology 42: 409-417.
13. DAKIN, R. 1829. Remarks on a cutaneous affection, produced by certain poisonous vegetables. Am. J. Med. Sci. 4: 98-100.
14. STEVENS, F. A. 1945. Status of the poison ivy extracts. J. Am. Med. Assoc. 127: 912-921.
15. LOWNEY, E. D. 1968. Immunological unresponsiveness to a contact sensitizer in man. J. Invest. Dermatol. 51: 411-417.
16. KORENBLAT, P. E., R. M. ROTHBERG, P. MINDEN & R. S. FARR. 1968. Immune response of human adults after oral and parenteral exposure to bovine serum albumin. J. Allergy 41: 226-235.
17. ROTHBERG, R. M. & R. S. FARR. 1965. Anti-bovine serum albumin and anti-alpha lactalbumin in the serum of children and adults. Pediatrics 35: 571-578.
18. RUSSELL, M. W., J. MESTECKY, B. A. JULIAN & J. H. GALLA. 1986. IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli. J. Clin. Immunol. 6: 74-86.
19. HUSBY, S., J. MESTECKY, Z. MOLDOVEANU, S. HOLLAND & C. O. ELSON. 1994. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J. Immunol. 152: 4663-4670.
20. WALDO, F. B., A. W. L. VANDEN WALL BAKE, J. MESTECKY & S. HUSBY. 1994. Suppression of the immune response by nasal immunization. Clin. Immunol. Immunopathol. 72: 30-34.
21. CLEMENTS, M. L. & B. R. MURPHY. 1986. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J. Clin. Microbiol. 23: 66-72.
22. WALDO, F. B. 1991. Nasal immunization with tetanus toxoid increases the subsequent systemic dimeric IgA1 antibody response to intramuscular immunization. J. Clin. Lab. Immunol. 34: 125-129.
23. BRANDTZAEG, P. 1995. Immunocompetent cells of the upper airway: Functions in normal and diseased mucosa. Eur. Arch. Oto-rhino-laryngol. 252: S8-S21.
24. BRANDTZAEG, P. 1989. Overview of the mucosal immune system. Curr. Top. Microbiol. Immunol. 146: 13-25.
25. SUN, J.-B., J. HOLMGREN & C. CZERKINSKY. 1994. Cholera Toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91: 10795-10799.